19 transactions in one company, from December 31, 2024 to March 1, 2025.
Where this insider traded.
| Company | Ticker | Trades | Bought | Sold |
|---|---|---|---|---|
| Aclaris Therapeutics, Inc. | ACRS | 19 | — | — |
19 in total, newest filings first.
| Company | Ticker | Insider | Date | Code | Shares | Price | Value | Held after |
|---|---|---|---|---|---|---|---|---|
| Aclaris Therapeutics, Inc. | ACRS | Joseph MonahanChiefDERIV | Mar 1 | MOption exercise | 10,925 | $0.00 | —? | 10,925derivatives |
| Aclaris Therapeutics, Inc. | ACRS | Joseph MonahanChiefDERIV | Mar 1 | MOption exercise | 50,000 | $0.00 | —? | 0derivatives |
| Aclaris Therapeutics, Inc. | ACRS | Joseph MonahanChief | Mar 1 | FTax withholding | 27,258 | $1.99 | $54K | 265,662 |
| Aclaris Therapeutics, Inc. | ACRS | Joseph MonahanChief | Mar 1 | MOption exercise | 10,925 | — | — | 292,920 |
| Aclaris Therapeutics, Inc. | ACRS | Joseph MonahanChief | Mar 1 | MOption exercise | 50,000 | — | — | 281,995 |
| Aclaris Therapeutics, Inc. | ACRS | Joseph MonahanChiefDERIV | Feb 3 | AAward | 293,500 | $0.00 | —? | 293,500derivatives |
| Aclaris Therapeutics, Inc. | ACRS | Joseph MonahanChiefDERIV | Feb 3 | AAward | 83,900 | $0.00 | —? | 83,900derivatives |
| Aclaris Therapeutics, Inc. | ACRS | Joseph MonahanChiefDERIV | Feb 1 | MOption exercise | 14,750 | $0.00 | —? | 44,250derivatives |
| Aclaris Therapeutics, Inc. | ACRS | Joseph MonahanChiefDERIV | Feb 1 | MOption exercise | 7,500 | $0.00 | —? | 15,000derivatives |
| Aclaris Therapeutics, Inc. | ACRS | Joseph MonahanChief | Feb 1 | FTax withholding | 11,317 | $2.48 | $28K | 231,995 |
| Aclaris Therapeutics, Inc. | ACRS | Joseph MonahanChief | Feb 1 | MOption exercise | 14,750 | — | — | 243,312 |
| Aclaris Therapeutics, Inc. | ACRS | Joseph MonahanChief | Feb 1 | MOption exercise | 7,500 | — | — | 228,562 |
| Aclaris Therapeutics, Inc. | ACRS | Joseph MonahanChiefDERIV | Jan 2 | MOption exercise | 17,380 | $0.00 | —? | 35,287derivatives |
| Aclaris Therapeutics, Inc. | ACRS | Joseph MonahanChiefDERIV | Jan 2 | AAward | 52,667 | $0.00 | —? | 52,667derivatives |
| Aclaris Therapeutics, Inc. | ACRS | Joseph MonahanChiefDERIV | Dec 31 | MOption exercise | 73,750 | $0.00 | —? | 73,750derivatives |
| Aclaris Therapeutics, Inc. | ACRS | Joseph MonahanChief | Jan 2 | FTax withholding | 8,914 | — | — | 221,062 |
| Aclaris Therapeutics, Inc. | ACRS | Joseph MonahanChief | Jan 2 | MOption exercise | 17,380 | — | — | 229,976 |
| Aclaris Therapeutics, Inc. | ACRS | Joseph MonahanChief | Dec 31 | FTax withholding | 32,937 | — | — | 212,596 |
| Aclaris Therapeutics, Inc. | ACRS | Joseph MonahanChief | Dec 31 | MOption exercise | 73,750 | — | — | 245,533 |